Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Yuyao Sun, Xiaoyan Li & Richard Bedlack. (2023) An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 23:1, pages 1-7.
Read now
Read now
Yuyao Sun, Richard Bedlack, Carmel Armon, Morgan Beauchamp, Tulio Bertorini, Robert Bowser, Mark Bromberg, James Caress, Gregory Carter, Jesse Crayle, Merit E. Cudkowicz, Jonathan D. Glass, Carlayne Jackson, Isaac Lund, Sarah Martin, Sabrina Paganoni, Gary Pattee, Dylan Ratner, Kristiana Salmon & Paul Wicks. (2022) ALSUntangled #64: butyrates. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:7-8, pages 638-643.
Read now
Read now
Andrea Barp, Francesca Gerardi, Andrea Lizio, Valeria Ada Sansone & Christian Lunetta. (2020) Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials. Expert Opinion on Emerging Drugs 25:2, pages 145-164.
Read now
Read now
R.S. Bedlack, Paul Wicks, Timothy Vaughan, Alicia Opie, Rebecca Blum, Amanda Dios & Ghazaleh Sadri-Vakili. (2019) Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 285-293.
Read now
Read now
Abigail DeLoach, Michael Cozart, Arianna Kiaei & Mahmoud Kiaei. (2015) A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies. Expert Opinion on Drug Discovery 10:10, pages 1099-1118.
Read now
Read now
. (2014) ALSUntangled No. 26: Lunasin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:7-8, pages 622-626.
Read now
Read now
Leonardo Cortez & Valerie Sim. (2014) The therapeutic potential of chemical chaperones in protein folding diseases. Prion 8:2, pages 197-202.
Read now
Read now
Lucio Tremolizzo, Paolo Messina, Elisa Conti, Gessica Sala, Matteo Cecchi, Luisa Airoldi, Roberta Pastorelli, Elisabetta Pupillo, Monica Bandettini Di Poggio, Massimiliano Filosto, Christian Lunetta, Cristina Agliardi, Franca Guerini, Jessica Mandrioli, Andrea Calvo, Ettore Beghi, Carlo Ferrarese, M.S. Cotelli, M. Corbo, E. Maestri, E. Georgoulopoulou, L. Marzorati, E. Susani, A. Arosio, A. Chiò, G. Fuda & F. Pisa. (2014) Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:1-2, pages 98-105.
Read now
Read now
Michael P Bova & Gene G Kinney. (2013) Emerging drug targets in amyotrophic lateral sclerosis. Expert Opinion on Orphan Drugs 1:1, pages 5-20.
Read now
Read now
Ali Aamer Habib & Hiroshi Mitsumoto. (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opinion on Emerging Drugs 16:3, pages 537-558.
Read now
Read now
Praveen Rajendran, David E. Williams, Emily Ho & Roderick H. Dashwood. (2011) Metabolism as a key to histone deacetylase inhibition. Critical Reviews in Biochemistry and Molecular Biology 46:3, pages 181-199.
Read now
Read now
Radhia Benmohamed, Anthony C. Arvanites, Jinho Kim, Robert J. Ferrante, Richard B. Silverman, Richard I. Morimoto & Donald R. Kirsch. (2011) Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 12:2, pages 87-96.
Read now
Read now
Magdalena Kuzma-Kozakiewicz & Hubert Kwiecinski. (2011) New therapeutic targets for amyotrophic lateral sclerosis. Expert Opinion on Therapeutic Targets 15:2, pages 127-143.
Read now
Read now
Daniel J. Amante, Jinho Kim, Samantha T. Carreiro, Andrew C. Cooper, Steven W. Jones, Ting Li, Jennifer P. Moody, Christina K. Edgerly, Olivia L. Bordiuk, Kerry Cormier, Karen Smith, Robert J. Ferrante & James Rusche. (2010) Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice. Amyotrophic Lateral Sclerosis 11:6, pages 520-530.
Read now
Read now
Stefano Zoccolella, Andrea Santamato & Paolo Lamberti. (2009) Current and emerging treatments for amyotrophic lateral sclerosis. Neuropsychiatric Disease and Treatment 5, pages 577-595.
Read now
Read now
Articles from other publishers (100)
Maria Lo Giudice, Antoniangela Cocco, Giorgio Reggiardo, Stefania Lalli & Alberto Albanese. (2023) Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect. Clinical Drug Investigation 43:12, pages 893-903.
Crossref
Crossref
Eleanor Roberts. (2023) A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis. EMJ Neurology, pages 2-12.
Crossref
Crossref
P. Corcia & P. Couratier. (2023) Clinical trials in rare diseases: A challenge for the near future. Revue Neurologique.
Crossref
Crossref
Arsh Haj Mohamad Ebrahim Ketabforoush, Rojin Chegini, Shirin Barati, Fatemeh Tahmasebi, Bardia Moghisseh, Mohammad Taghi Joghataei, Faezeh Faghihi & Fereshteh Azedi. (2023) Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series. Biomedicine & Pharmacotherapy 160, pages 114378.
Crossref
Crossref
Zeynep YILDIRIM, Dicle Naz TOKTAŞ, Öznur DEMİR, Zülfiye GÜL & Burcu ŞEN UTSUKARÇİ. (2023) Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi YaklaşımlarıAn Evaluation of Amyotrophic Lateral Sclerosis and Current Situation in Its Treatment. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Zoe Castles, Lauren Buckett, Leanne Jiang, Frederik J. Steyn & Shyuan T. Ngo. 2023. Diet and Nutrition in Neurological Disorders. Diet and Nutrition in Neurological Disorders
123
140
.
Winanto Ng & Shi-Yan Ng. (2022) Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity. Translational Neurodegeneration 11:1.
Crossref
Crossref
Nirnay Samanta, Yasser B. Ruiz‐Blanco, Zamira Fetahaj, David Gnutt, Carter Lantz, Joseph A. Loo, Elsa Sanchez‐Garcia & Simon Ebbinghaus. (2022) Superoxide Dismutase 1 Folding Stability as a Target for Molecular Tweezers in SOD1‐Related Amyotrophic Lateral Sclerosis. ChemBioChem 23:21.
Crossref
Crossref
Zhipeng Qi, Jiashuo Li, Minghui Li, Xianchao Du, Lei Zhang, Shuang Wang, Bin Xu, Wei Liu, Zhaofa Xu & Yu Deng. (2021) The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia. Cellular and Molecular Neurobiology 42:8, pages 2459-2472.
Crossref
Crossref
Edoardo Parrella, Vanessa Porrini, Ilaria Scambi, Michele M. Gennari, Cristina Gussago, Oluwamolakun Bankole, Marina Benarese, Raffaella Mariotti & Marina Pizzi. (2022) Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Matthew E. R. Butchbach & Rod C. Scott. (2022) Biological networks and complexity in early-onset motor neuron diseases. Frontiers in Neurology 13.
Crossref
Crossref
Johannes Dorst & Angela Genge. (2022) Clinical studies in amyotrophic lateral sclerosis. Current Opinion in Neurology 35:5, pages 686-692.
Crossref
Crossref
Jasmine A. Fels, Jalia Dash, Kent Leslie, Giovanni Manfredi & Hibiki Kawamata. (2022)
Effects of
PB‐TURSO
on the transcriptional and metabolic landscape of sporadic
ALS
fibroblasts
. Annals of Clinical and Translational Neurology 9:10, pages 1551-1564.
Crossref
Crossref
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, Dylan Neel, Donatienne Van Weehaeghe, James D. Berry & Sabrina Paganoni. (2022) Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents. Drugs 82:13, pages 1367-1388.
Crossref
Crossref
Kareem Khalaf, Paolo Tornese, Antoniangela Cocco & Alberto Albanese. (2022) Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases. Translational Neurodegeneration 11:1.
Crossref
Crossref
Caroline Perner & Elke Krüger. (2022) Endoplasmic Reticulum Stress and Its Role in Homeostasis and Immunity of Central and Peripheral Neurons. Frontiers in Immunology 13.
Crossref
Crossref
Mariana Dantas de Carvalho Vilar, Sancha Helena de Lima Vale, Eliane Lopes Rosado, Mário Emílio Teixeira Dourado Júnior, José Brandão-Neto & Lúcia Leite-Lais. (2022) Intestinal Microbiota and Sclerosis Lateral Amyotrophic. REVISTA CIÊNCIAS EM SAÚDE 12:1, pages 3-13.
Crossref
Crossref
Samantha N. Cobos & Mariana P. Torrente. (2022) Epidrugs in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia: Contextualizing a Role for Histone Kinase Inhibition in Neurodegenerative Disease. ACS Pharmacology & Translational Science 5:2, pages 134-137.
Crossref
Crossref
Vishal Kumar, Satyabrata Kundu, Arti Singh & Shamsher Singh. (2022) Understanding the Role of Histone Deacetylase and their Inhibitors in
Neurodegenerative Disorders: Current Targets and Future Perspective. Current Neuropharmacology 20:1, pages 158-178.
Crossref
Crossref
Michail S. Kukharsky, Veronika I. Skvortsova, Sergey O. Bachurin & Vladimir L. Buchman. (2020) In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches. Medicinal Research Reviews 41:5, pages 2804-2822.
Crossref
Crossref
Caroline Paula Mescka, Daniella de Moura Coelho, Angela Sitta, Felipe Catarino, Bruna Donida, Andrea Pereira Rosa, Esteban Alberto Gonzalez, Camila Vieira Pinheiro, Fernanda Poletto, Guilherme Baldo, Carlos Severo Dutra-Filho & Carmen Regla Vargas. (2021) Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD. Metabolic Brain Disease 36:5, pages 1015-1027.
Crossref
Crossref
Salome Azoulay-Ginsburg, Michela Di Salvio, Michal Weitman, Michal Afri, Sara Ribeiro, Simon Ebbinghaus, Gianluca Cestra & Arie Gruzman. (2021) Chemical chaperones targeted to the endoplasmic reticulum (ER) and lysosome prevented neurodegeneration in a C9orf72 repeat expansion drosophila amyotrophic lateral sclerosis (ALS) model. Pharmacological Reports 73:2, pages 536-550.
Crossref
Crossref
Yvonne E. Klingl, Donya Pakravan & Ludo Van Den Bosch. (2020) Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis. British Journal of Pharmacology 178:6, pages 1353-1372.
Crossref
Crossref
Viraj P. Ichhaporia & Linda M. Hendershot. (2021) Role of the HSP70 Co-Chaperone SIL1 in Health and Disease. International Journal of Molecular Sciences 22:4, pages 1564.
Crossref
Crossref
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, Christopher J. McDermott, Orla Hardiman, Jeremy M. Shefner, Ammar Al-Chalabi, William Huynh, Merit Cudkowicz, Paul Talman, Leonard H. Van den Berg, Thanuja Dharmadasa, Paul Wicks, Claire Reilly & Martin R. Turner. (2020) Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nature Reviews Neurology 17:2, pages 104-118.
Crossref
Crossref
Nicoletta Nuzziello & Maria Liguori. 2021. Medical Epigenetics. Medical Epigenetics
559
581
.
Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Eric A. Macklin, James D. Berry, Michael A. Elliott, Samuel Maiser, Chafic Karam, James B. Caress, Margaret Ayo Owegi, Adam Quick, James Wymer, Stephen A. Goutman, Daragh Heitzman, Terry D. Heiman‐Patterson, Carlayne E. Jackson, Colin Quinn, Jeffrey D. Rothstein, Edward J. Kasarskis, Jonathan Katz, Liberty Jenkins, Shafeeq Ladha, Timothy M. Miller, Stephen N. Scelsa, Tuan H. Vu, Christina N. Fournier, Jonathan D. Glass, Kristin M. Johnson, Andrea Swenson, Namita A. Goyal, Gary L. Pattee, Patricia L. Andres, Suma Babu, Marianne Chase, Derek Dagostino, Meghan Hall, Gale Kittle, Matthew Eydinov, Michelle McGovern, Joseph Ostrow, Lindsay Pothier, Rebecca Randall, Jeremy M. Shefner, Alexander V. Sherman, Maria E. St Pierre, Eric Tustison, Prasha Vigneswaran, Jason Walker, Hong Yu, James Chan, Janet Wittes, Zi‐Fan Yu, Joshua Cohen, Justin Klee, Kent Leslie, Rudolph E. Tanzi, Walter Gilbert, Patrick D. Yeramian, David Schoenfeld & Merit E. Cudkowicz. (2020)
Long‐term survival of participants in the
CENTAUR
trial of sodium phenylbutyrate‐taurursodiol in
amyotrophic lateral sclerosis
. Muscle & Nerve 63:1, pages 31-39.
Crossref
Crossref
Tiziana Petrozziello, Amanda M. Dios, Kaly A. Mueller, Christine A. Vaine, William T. Hendriks, Kelly E. Glajch, Alexandra N. Mills, Kotchaphorn Mangkalaphiban, Ellen B. Penney, Naoto Ito, Cara Fernandez-Cerado, Gierold Paul A. Legarda, M. Salvie Velasco-Andrada, Patrick J. Acuña, Mark A. Ang, Edwin L. Muñoz, Cid Czarina E. Diesta, Regina Macalintal-Canlas, Geraldine Acuña, Nutan Sharma, Laurie J. Ozelius, D. Cristopher Bragg & Ghazaleh Sadri-Vakili. (2020) SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene. PLOS ONE 15:12, pages e0243655.
Crossref
Crossref
. (2020) Sodium Phenylbutyrate–Taurursodiol for ALS. New England Journal of Medicine 383:23, pages 2293-2294.
Crossref
Crossref
Tiziana Petrozziello, Alexandra N. Mills, Christine A. Vaine, Ellen B. Penney, Cara Fernandez-Cerado, Gierold Paul A. Legarda, M. Salvie Velasco-Andrada, Patrick J. Acuña, Mark A. Ang, Edwin L. Muñoz, Cid Czarina E. Diesta, Regina Macalintal-Canlas, Geraldine Acuña-Sunshine, Laurie J. Ozelius, Nutan Sharma, D. Cristopher Bragg & Ghazaleh Sadri-Vakili. (2020) Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex. Neurobiology of Disease 144, pages 105032.
Crossref
Crossref
Sabrina PaganoniEric A. MacklinSuzanne HendrixJames D. BerryMichael A. ElliottSamuel MaiserChafic KaramJames B. CaressMargaret A. OwegiAdam QuickJames WymerStephen A. GoutmanDaragh HeitzmanTerry Heiman-PattersonCarlayne E. JacksonColin QuinnJeffrey D. RothsteinEdward J. KasarskisJonathan KatzLiberty JenkinsShafeeq LadhaTimothy M. MillerStephen N. ScelsaTuan H. VuChristina N. FournierJonathan D. GlassKristin M. JohnsonAndrea SwensonNamita A. GoyalGary L. PatteePatricia L. AndresSuma BabuMarianne ChaseDerek DagostinoSamuel P. DicksonNoel EllisonMeghan HallKent HendrixGale KittleMichelle McGovernJoseph OstrowLindsay PothierRebecca RandallJeremy M. ShefnerAlexander V. ShermanEric TustisonPrasha VigneswaranJason WalkerHong YuJames ChanJanet WittesJoshua CohenJustin KleeKent LeslieRudolph E. TanziWalter GilbertPatrick D. YeramianDavid SchoenfeldMerit E. Cudkowicz. (2020) Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis. New England Journal of Medicine 383:10, pages 919-930.
Crossref
Crossref
Michael Benatar & Michael P. McDermott. (2020) Incremental Gains in the Battle against ALS. New England Journal of Medicine 383:10, pages 979-980.
Crossref
Crossref
Heike J. Wobst, Korrie L. Mack, Dean G. Brown, Nicholas J. Brandon & James Shorter. (2020) The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future. Medicinal Research Reviews 40:4, pages 1352-1384.
Crossref
Crossref
Simona Sanna, Sonia Esposito, Alessandra Masala, Paola Sini, Gabriele Nieddu, Manuela Galioto, Milena Fais, Ciro Iaccarino, Gianluca Cestra & Claudia Crosio. (2020) HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. Cell Death & Disease 11:5.
Crossref
Crossref
Rachel Kuta, Nancy Larochelle, Mario Fernandez, Arun Pal, Sandra Minotti, Michael Tibshirani, Kyle St. Louis, Benoit J. Gentil, Josephine N. Nalbantoglu, Andreas Hermann & Heather D. Durham. (2020) Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models. Cell Stress and Chaperones 25:1, pages 173-191.
Crossref
Crossref
Coco Newton. 2020. Integrative and Functional Medical Nutrition Therapy. Integrative and Functional Medical Nutrition Therapy
863
912
.
Keisuke Kitakaze, Shusuke Taniuchi, Eri Kawano, Yoshimasa Hamada, Masato Miyake, Miho Oyadomari, Hirotatsu Kojima, Hidetaka Kosako, Tomoko Kuribara, Suguru Yoshida, Takamitsu Hosoya & Seiichi Oyadomari. (2019) Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity. eLife 8.
Crossref
Crossref
Elisabeth Rossaert, Eveliina Pollari, Tom Jaspers, Lawrence Van Helleputte, Matthew Jarpe, Philip Van Damme, Katrien De Bock, Matthieu Moisse & Ludo Van Den Bosch. (2019) Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathologica Communications 7:1.
Crossref
Crossref
Amanda M. Dios, Suma Babu, Eric J. Granucci, Kaly A. Mueller, Alexandra N. Mills, Mohamad J. Alshikho, Nicole R. Zürcher, Paul Cernasov, Tonya M. Gilbert, Jonathan D. Glass, James D. Berry, Nazem Atassi, Jacob M. Hooker & Ghazaleh Sadri‐Vakili. (2019) Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence. Muscle & Nerve 60:4, pages 443-452.
Crossref
Crossref
Samantha N. Cobos, Seth A. Bennett & Mariana P. Torrente. (2019) The impact of histone post-translational modifications in neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865:8, pages 1982-1991.
Crossref
Crossref
María Berdasco & Manel Esteller. (2018) Clinical epigenetics: seizing opportunities for translation. Nature Reviews Genetics 20:2, pages 109-127.
Crossref
Crossref
Seth A. Bennett, Royena Tanaz, Samantha N. Cobos & Mariana P. Torrente. (2019) Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Translational Research 204, pages 19-30.
Crossref
Crossref
Eva Pigna, Elena Simonazzi, Krizia Sanna, Krzysztof Marian Bernadzki, Tomek Proszynski, Constantin Heil, Daniela Palacios, Sergio Adamo & Viviana Moresi. (2019) Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine 40, pages 717-732.
Crossref
Crossref
Shabir Ahmad GanaiShabir Ahmad Ganai. 2019. Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders. Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders
39
58
.
Kewal K. JainKewal K. Jain. 2019. The Handbook of Neuroprotection. The Handbook of Neuroprotection
609
641
.
Malgorzata Ziemka-Nalecz, Joanna Jaworska, Joanna Sypecka & Teresa Zalewska. (2018) Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?. Journal of Neuropathology & Experimental Neurology 77:10, pages 855-870.
Crossref
Crossref
Daniela Buonvicino, Roberta Felici, Giuseppe Ranieri, Riccardo Caramelli, Andrea Lapucci, Leonardo Cavone, Mirko Muzzi, Lorena Di Pietro, Camilla Bernardini, Clemens Zwergel, Sergio Valente, Antonello Mai & Alberto Chiarugi. (2018) Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice. Neuroscience 379, pages 228-238.
Crossref
Crossref
Mark T. W. Ebbert, Rebecca J. Lank & Veronique V. Belzil. 2018. RNA Metabolism in Neurodegenerative Diseases. RNA Metabolism in Neurodegenerative Diseases
1
29
.
Yong-guo Zhang, Shaoping Wu, Jianxun Yi, Yinglin Xia, Dapeng Jin, Jingsong Zhou & Jun Sun. (2017) Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis. Clinical Therapeutics 39:2, pages 322-336.
Crossref
Crossref
Pablo Rozas, Leslie Bargsted, Francisca Martínez, Claudio Hetz & Danilo B. Medinas. (2017) The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability. Neuroscience Letters 636, pages 9-15.
Crossref
Crossref
Hristelina Ilieva & Nicholas J. Maragakis. 2017. Neurodegenerative Diseases. Neurodegenerative Diseases
191
210
.
Kristi M. Anderson & R. Lee Mosley. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology
681
711
.
Vijay Kumar, Asimul Islam, Md. Imtaiyaz Hassan & Faizan Ahmad. (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. European Journal of Medicinal Chemistry 121, pages 903-917.
Crossref
Crossref
Veronique V. Belzil, Rebecca B. Katzman & Leonard Petrucelli. (2016) ALS and FTD: an epigenetic perspective. Acta Neuropathologica 132:4, pages 487-502.
Crossref
Crossref
Chia-Hsiang Hsueh, Kenta Yoshida, Ping Zhao, Timothy W. Meyer, Lei Zhang, Shiew-Mei Huang & Kathleen M. Giacomini. (2016) Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3. Molecular Pharmaceutics 13:9, pages 3130-3140.
Crossref
Crossref
Heather M. Schmitt, Cassandra L. Schlamp & Robert W. Nickells. (2016) Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells. Neuroscience Letters 625, pages 11-15.
Crossref
Crossref
Pamela Milani & Ernest Fraenkel. 2016. Epigenetic Biomarkers and Diagnostics. Epigenetic Biomarkers and Diagnostics
519
537
.
Ankit Tripathi, Renu Sharma, Noopur Kejriwal, Rashmi K. Ambasta & Pravir Kumar. 2016. Epigenetic Advancements in Cancer. Epigenetic Advancements in Cancer
177
205
.
Mark F. McCarty, James J. DiNicolantonio & James H. O’Keefe. (2015) Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1. Medical Hypotheses 85:5, pages 631-639.
Crossref
Crossref
Luis M. Valor. (2015) Epigenetic-based therapies in the preclinical and clinical treatment of Huntington's disease. The International Journal of Biochemistry & Cell Biology 67, pages 45-48.
Crossref
Crossref
Giovanna Morello & Sebastiano Cavallaro. (2015) Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy. Future Medicinal Chemistry 7:10, pages 1335-1359.
Crossref
Crossref
Ximena Paez-Colasante, Claudia Figueroa-Romero, Stacey A. Sakowski, Stephen A. Goutman & Eva L. Feldman. (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nature Reviews Neurology 11:5, pages 266-279.
Crossref
Crossref
Michael Jablonski, David S. Miller, Piera Pasinelli & Davide Trotti. (2015) ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis. Brain Research 1607, pages 1-14.
Crossref
Crossref
Nam-Hee KimMin Oh Lee. (2015) Update of Therapeutic Clinical Trials for Amyotrophic Lateral Sclerosis. Korean Journal of Clinical Neurophysiology 17:1, pages 1.
Crossref
Crossref
Alessandro Didonna & Puneet Opal. (2014)
The promise and perils of
HDAC
inhibitors in neurodegeneration
. Annals of Clinical and Translational Neurology 2:1, pages 79-101.
Crossref
Crossref
Fabio Coppedè. (2014) The potential of epigenetic therapies in neurodegenerative diseases. Frontiers in Genetics 5.
Crossref
Crossref
Sabrina Paganoni, Merit Cudkowicz & James D Berry. (2014) Outcome measures in amyotrophic lateral sclerosis clinical trials. Clinical Investigation 4:7, pages 605-618.
Crossref
Crossref
Anna Nogalska, Carla D'Agostino, W. King Engel & Valerie Askanas. (2014) Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-β42 in an in vitro-model of inclusion-body myositis. Neurobiology of Disease 65, pages 93-101.
Crossref
Crossref
Dmitry A. Chistiakov, Igor A. Sobenin, Alexander N. Orekhov & Yuri V. Bobryshev. (2014) Role of Endoplasmic Reticulum Stress in Atherosclerosis and Diabetic Macrovascular Complications. BioMed Research International 2014, pages 1-14.
Crossref
Crossref
Sung Won Kim, Jacob M. Hooker, Nicola Otto, Khaing Win, Lisa Muench, Colleen Shea, Pauline Carter, Payton King, Alicia E. Reid, Nora D. Volkow & Joanna S. Fowler. (2013) Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. Nuclear Medicine and Biology 40:7, pages 912-918.
Crossref
Crossref
Sophie Schweizer, Andreas Meisel & Stefanie Märschenz. (2013) Epigenetic Mechanisms in Cerebral Ischemia. Journal of Cerebral Blood Flow & Metabolism 33:9, pages 1335-1346.
Crossref
Crossref
Marta Zamarbide, Eva Martinez-Pinilla, Ana Ricobaraza, Tomás Aragón, Rafael Franco & Alberto Pérez-Mediavilla. (2013) Phenyl Acyl Acids Attenuate the Unfolded Protein Response in Tunicamycin-Treated Neuroblastoma Cells. PLoS ONE 8:8, pages e71082.
Crossref
Crossref
Alessandra Chesi, Brett T Staahl, Ana Jovičić, Julien Couthouis, Maria Fasolino, Alya R Raphael, Tomohiro Yamazaki, Laura Elias, Meraida Polak, Crystal Kelly, Kelly L Williams, Jennifer A Fifita, Nicholas J Maragakis, Garth A Nicholson, Oliver D King, Robin Reed, Gerald R Crabtree, Ian P Blair, Jonathan D Glass & Aaron D Gitler. (2013) Exome sequencing to identify de novo mutations in sporadic ALS trios. Nature Neuroscience 16:7, pages 851-855.
Crossref
Crossref
Mauro Cozzolino, Alberto Ferri, Cristiana Valle & Maria Teresa Carrì. (2013) Mitochondria and ALS: Implications from novel genes and pathways. Molecular and Cellular Neuroscience 55, pages 44-49.
Crossref
Crossref
Nicholas W. Morrell, Stephen L. Archer, Albert DeFelice, Steven Evans, Monica Fiszman, Thomas Martin, Muriel Saulnier, Marlene Rabinovitch, Ralph Schermuly, Duncan Stewart, Hubert Truebel, Gennyne Walker & Kurt R. Stenmark. (2013) Anticipated Classes of New Medications and Molecular Targets for Pulmonary Arterial Hypertension. Pulmonary Circulation 3:1, pages 226-244.
Crossref
Crossref
Michael P Bova & Gene G Kinney. (2013) Emerging drug targets in amyotrophic lateral sclerosis. Expert Opinion on Orphan Drugs 1:1, pages 5-20.
Crossref
Crossref
Angela Nebbioso, Vincenzo Carafa, Rosaria Benedetti & Lucia Altucci. (2012) Trials with ‘epigenetic’ drugs: An update. Molecular Oncology 6:6, pages 657-682.
Crossref
Crossref
Mauro CozzolinoMaria Grazia PesaresiValeria GerbinoJulian GrosskreutzMaria Teresa Carrì. (2012) Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention. Antioxidants & Redox Signaling 17:9, pages 1277-1330.
Crossref
Crossref
Valerie Askanas, W. King Engel & Anna Nogalska. (2012) Pathogenic Considerations in Sporadic Inclusion-Body Myositis, a Degenerative Muscle Disease Associated With Aging and Abnormalities of Myoproteostasis. Journal of Neuropathology & Experimental Neurology 71:8, pages 680-693.
Crossref
Crossref
Nicholas J. Maragakis. 2012. Translational Neuroscience. Translational Neuroscience
214
227
.
Nazem Atassi, David Schoenfeld & Merit Cudkowicz. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology
273
283
.
. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology
215
308
.
Valerie Askanas, W. King Engel & Anna Nogalska. 2012. Muscle Aging, Inclusion‐Body Myositis and Myopathies. Muscle Aging, Inclusion‐Body Myositis and Myopathies
109
145
.
Benjamin Chee Chuan Cheah, Steve Vucic & Matthew Colm Kiernan. (2012) Potential utility of biomarkers in the diagnosis and treatment of amyotrophic lateral sclerosis. Clinical Investigation 2:1, pages 107-117.
Crossref
Crossref
Luisa Rossi, Cristiana Valle & Maria Teresa Carrì. (2012) Altered Gene Expression, Mitochondrial Damage and Oxidative Stress: Converging Routes in Motor Neuron Degeneration. International Journal of Cell Biology 2012, pages 1-9.
Crossref
Crossref
Krishnamoorthy Srinivasan & Shyam S. Sharma. (2011) Sodium phenylbutyrate ameliorates focal cerebral ischemic/reperfusion injury associated with comorbid type 2 diabetes by reducing endoplasmic reticulum stress and DNA fragmentation. Behavioural Brain Research 225:1, pages 110-116.
Crossref
Crossref
Anna Golubitzky, Phyllis Dan, Sarah Weissman, Gabriela Link, Jakob D. Wikstrom & Ann Saada. (2011) Screening for Active Small Molecules in Mitochondrial Complex I Deficient Patient's Fibroblasts, Reveals AICAR as the Most Beneficial Compound. PLoS ONE 6:10, pages e26883.
Crossref
Crossref
Tommaso Iannitti & Beniamino Palmieri. (2012) Clinical and Experimental Applications of Sodium Phenylbutyrate. Drugs in R&D 11:3, pages 227-249.
Crossref
Crossref
Tommaso Iannitti & Beniamino Palmieri. (2012) Clinical and Experimental Applications of Sodium Phenylbutyrate. Drugs in R & D 11:3, pages 227-249.
Crossref
Crossref
Peter I. Joyce, Pietro Fratta, Elizabeth M. C. Fisher & Abraham Acevedo-Arozena. (2011) SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Mammalian Genome 22:7-8, pages 420-448.
Crossref
Crossref
Lei Lv, Yan Sun, Xiang Han, Cong-cong Xu, Yu-Ping Tang & Qiang Dong. (2011) Valproic acid improves outcome after rodent spinal cord injury: Potential roles of histone deacetylase inhibition. Brain Research 1396, pages 60-68.
Crossref
Crossref
Philippa D. PowellChristine Bellanné-Chantelot, Sarah E. FlanaganSian EllardRaoul Rooman, Khalid HussainMars SkaePeter ClaytonPascale de Lonlay, Mark J. DunneKaren E. Cosgrove. (2011) In Vitro Recovery of ATP-Sensitive Potassium Channels in β-Cells From Patients With Congenital Hyperinsulinism of Infancy. Diabetes 60:4, pages 1223-1228.
Crossref
Crossref
Wenbo Zhou, Kathryn Bercury, Jessica Cummiskey, Nancy Luong, Jacob Lebin & Curt R. Freed. (2011) Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease. Journal of Biological Chemistry 286:17, pages 14941-14951.
Crossref
Crossref
Paul H. Gordon. (2011) Amyotrophic Lateral Sclerosis. CNS Drugs 25:1, pages 1-15.
Crossref
Crossref
Tetsuo MinaminoIssei KomuroMasafumi Kitakaze. (2010) Endoplasmic Reticulum Stress As a Therapeutic Target in Cardiovascular Disease. Circulation Research 107:9, pages 1071-1082.
Crossref
Crossref
B. Ruthrotha Selvi, Jean-Christophe Cassel, Tapas K. Kundu & Anne-Laurence Boutillier. (2010) Tuning acetylation levels with HAT activators: Therapeutic strategy in neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1799:10-12, pages 840-853.
Crossref
Crossref
Joel M GottesfeldMassimo Pandolfo. (2009) Development of histone deacetylase inhibitors as therapeutics for neurological disease. Future Neurology 4:6, pages 775-784.
Crossref
Crossref
De-Maw Chuang, Yan Leng, Zoya Marinova, Hyeon-Ju Kim & Chi-Tso Chiu. (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends in Neurosciences 32:11, pages 591-601.
Crossref
Crossref
Rocio G Urdinguio, Jose V Sanchez-Mut & Manel Esteller. (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. The Lancet Neurology 8:11, pages 1056-1072.
Crossref
Crossref
Michael Benatar, Jerome Kurent & Dan H Moore. (2009) Treatment for familial amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref